Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C-KAD in age-related low-grade nuclear cataract
NCT06365762Phase 2Completed
- Sponsor
- Livionex
- Start
- Jan 2006
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of edetate disodium in nuclear cataract (NS) (3 arms), sponsored by Livionex. Primary endpoint: Contrast Sensitivity (Mesopic) Responder Analysis at Day 120. Started Jan 2006; status: completed.
02
Drugs
edetate disodium
03
Conditions
nuclear cataract (NS)
Beyond the preview
Go deeper on NCT06365762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06365762.